Search research articles
Contact Us
Filters
Showing results (131-140 of 219) with videos related to
Page
of 22
Sort By:
Thrombosis and Haemostasis
|
January 11, 1993
Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate
K Huber, R Beckmann, P Probst, et al.
The Journal of Biological Chemistry
|
March 8, 1996
Differential regulation of vitronectin in mice and humans in vitro
D Seiffert, S A Curriden, D Jenne, et al.
Acta Haematologica Polonica
|
January 1, 1994
Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease
K Bykowska, M Letowska, J Sabliński, et al.
Klinische Wochenschrift
|
November 15, 1988
[Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct]
C Baumgartner, K Huber, F Holzner, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?
G Christ, K Kostner, M Zehetgruber, et al.
American Journal of Hematology
|
January 1, 1994
Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency
K Okajima, I Kohno, G Soe, et al.
Anticancer Research
|
January 1, 1997
Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells
H Tsuchiya, C Sunayama, G Okada, et al.
Clinical Genetics
|
April 29, 1998
Genotype-phenotype correlation in myotonic dystrophy
E B Gharehbaghi-Schnell, J Finsterer, I Korschineck, et al.
Cancer Letters
|
June 5, 1996
Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro
K Addo-Boadu, J Wojta, G Christ, et al.
Immunopharmacology
|
June 1, 1996
Effect of protein C inhibitor (PCI) on in vitro fertilization
X Zheng, M Zechmeister-Machhart, P Uhrin, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 219) with videos related to
Sort By:
Page
of 22
Thrombosis and Haemostasis
|
January 11, 1993
Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate
K Huber, R Beckmann, P Probst, et al.
The Journal of Biological Chemistry
|
March 8, 1996
Differential regulation of vitronectin in mice and humans in vitro
D Seiffert, S A Curriden, D Jenne, et al.
Acta Haematologica Polonica
|
January 1, 1994
Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease
K Bykowska, M Letowska, J Sabliński, et al.
Klinische Wochenschrift
|
November 15, 1988
[Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct]
C Baumgartner, K Huber, F Holzner, et al.
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?
G Christ, K Kostner, M Zehetgruber, et al.
American Journal of Hematology
|
January 1, 1994
Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency
K Okajima, I Kohno, G Soe, et al.
Anticancer Research
|
January 1, 1997
Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells
H Tsuchiya, C Sunayama, G Okada, et al.
Clinical Genetics
|
April 29, 1998
Genotype-phenotype correlation in myotonic dystrophy
E B Gharehbaghi-Schnell, J Finsterer, I Korschineck, et al.
Cancer Letters
|
June 5, 1996
Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro
K Addo-Boadu, J Wojta, G Christ, et al.
Immunopharmacology
|
June 1, 1996
Effect of protein C inhibitor (PCI) on in vitro fertilization
X Zheng, M Zechmeister-Machhart, P Uhrin, et al.
Page
of 22